Loading
Life sciences · Journal article
Private Practice Infectious Disease · October 16, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract: Infectious disease (ID) physicians have long provided demonstrable value to patients, healthcare systems, and the broader community. Over more than 25 years of peer-reviewed literature, ID specialists have been associated with reduced mortality, shorter hospital stays, lower costs, and improved antimicrobial stewardship outcomes. Despite this well-documented clinical and economic impact, ID physicians remain among the lowest-compensated internal medicine subspecialists in the United States. This paper synthesizes the historical and contemporary evidence for the value of ID physicians, with particular attention to private practice, and proposes a framework for practice models that align compensation with demonstrated value. Key domains include directive clinical care, outpatient parenteral antimicrobial therapy (OPAT), antimicrobial stewardship, infection prevention, emerging pathogen management, and lifestyle considerations unique to the specialty.